Literature DB >> 4058620

Why the kidney?

A J Erslev, J Caro, A Besarab.   

Abstract

Severe erythrocytosis is associated with increased whole blood viscosity and impaired blood flow. Since a reduced blood flow will cause tissue hypoxia and since tissue hypoxia is associated with increased synthesis of erythropoietin, erythrocytosis per se should cause an increase in the rate of red cell production. This, however, does not occur and severe erythrocytosis in patients with polycythemia vera does not lead to increased synthesis of erythropoietin. We propose here that the reason for this discrepancy is that decreased blood flow to the kidneys, the site of erythropoietin synthesis, does not cause renal tissue hypoxia. The oxygen tension in the kidneys is to a great extent determined by the consumption of oxygen used for sodium reabsorption and since sodium reabsorption is roughly proportional to glomerular filtration, a decreased flow of blood should be matched by a decreased oxygen consumption leaving the tissue tension of oxygen unchanged. Consequently, the location of an oxygen sensor in the kidneys controlling erythropoietin production appears to be most fortuitous since it prevents the development of a vicious circle, with erythrocytosis causing more erythrocytosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4058620     DOI: 10.1159/000183585

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Modulation of erythropoietin formation by changes in blood volume in conscious dogs.

Authors:  H Ehmke; A Just; K U Eckardt; P B Persson; C Bauer; H R Kirchheim
Journal:  J Physiol       Date:  1995-10-01       Impact factor: 5.182

2.  A genetic variation associated with plasma erythropoietin and a non-coding transcript of PRKAR1A in sickle cell disease.

Authors:  Xu Zhang; Binal N Shah; Wei Zhang; Santosh L Saraf; Galina Miasnikova; Adelina Sergueeva; Tatiana Ammosova; Xiaomei Niu; Mehdi Nouraie; Sergei Nekhai; Oswaldo Castro; Mark T Gladwin; Josef T Prchal; Joe G N Garcia; Roberto F Machado; Victor R Gordeuk
Journal:  Hum Mol Genet       Date:  2016-10-15       Impact factor: 6.150

Review 3.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

Review 4.  Physiologic and molecular biology of erythropoietin.

Authors:  A J Erslev; J Caro
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

5.  Low total haemoglobin mass, blood volume and aerobic capacity in men with type 1 diabetes.

Authors:  Anne S Koponen; Juha E Peltonen; Marja K Päivinen; Jyrki M Aho; Harriet J Hägglund; Arja L Uusitalo; Harri J Lindholm; Heikki O Tikkanen
Journal:  Eur J Appl Physiol       Date:  2012-11-06       Impact factor: 3.078

Review 6.  Erythropoietin.

Authors:  W Jelkmann
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

7.  Clinical iron deficiency disturbs normal human responses to hypoxia.

Authors:  Matthew C Frise; Hung-Yuan Cheng; Annabel H Nickol; M Kate Curtis; Karen A Pollard; David J Roberts; Peter J Ratcliffe; Keith L Dorrington; Peter A Robbins
Journal:  J Clin Invest       Date:  2016-05-03       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.